Celiac disease was confirmed by highly elevated titers of anti-tissue transglutaminase (tTG) antibodies, anti-deamidated gliadin peptide (DGP) antibodies, and anti-endomysial antibodies (EMA), results exceeded the upper limit of normal by 10-fold. The gene discussed is TGM2; the disease is celiac disease.